Ignite Creation Date:
2024-05-06 @ 3:22 PM
Last Modification Date:
2024-10-26 @ 1:47 PM
Study NCT ID:
NCT04602884
Status:
COMPLETED
Last Update Posted:
2022-02-07
First Post:
2020-10-21
Brief Title:
Early Detection of COVID-19 Using Breath Analysis
Sponsor:
Scentech Medical Technologies Ltd
Organization:
Scentech Medical Technologies Ltd
Study Overview
Official Title:
Early Detection of the 2019 Novel Coronavirus SARS-CoV-2 Using Breath Analysis First Cross-Sectional Study
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
COVID-19
Brief Summary:
EARLY DETECTION OF COVID-19 USING BREATH ANALYSIS- FIRST CROSS-SECTIONAL STUDY
Detailed Description:
Primary objective- to identify and evaluate a set of biomarkers that represent both the genetic expression of the virus itself SARS-CoV-2 and the metabolic activity of the immune systems response to the virus
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None